Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gene therapy for visual loss: Opportunities and concerns
Jia Hui Lee, Jiang-Hui Wang, Jinying Chen, et al.
Progress in Retinal and Eye Research (2018) Vol. 68, pp. 31-53
Closed Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

Immune responses to retinal gene therapy using adeno-associated viral vectors – Implications for treatment success and safety
Kirsten Bucher, Eduardo Rodríguez‐Bocanegra, Daniyar Dauletbekov, et al.
Progress in Retinal and Eye Research (2020) Vol. 83, pp. 100915-100915
Closed Access | Times Cited: 161
Gene therapy for neurodegenerative disorders: advances, insights and prospects
Wei Chen, Yang Hu, Dianwen Ju
Acta Pharmaceutica Sinica B (2020) Vol. 10, Iss. 8, pp. 1347-1359
Open Access | Times Cited: 159
Progress in treating inherited retinal diseases: Early subretinal gene therapy clinical trials and candidates for future initiatives
Alexandra V. Garafalo, Artur V. Cideciyan, Elise Héon, et al.
Progress in Retinal and Eye Research (2019) Vol. 77, pp. 100827-100827
Open Access | Times Cited: 157
Inherited retinal diseases: Linking genes, disease-causing variants, and relevant therapeutic modalities
Nina Schneider, Yogapriya Sundaresan, Prakadeeswari Gopalakrishnan, et al.
Progress in Retinal and Eye Research (2021) Vol. 89, pp. 101029-101029
Closed Access | Times Cited: 129
Retinitis Pigmentosa: Progress in Molecular Pathology and Biotherapeutical Strategies
Wanqin Liu, Shanshan Liu, Ping Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4883-4883
Open Access | Times Cited: 94
Recent advances in the treatment and delivery system of diabetic retinopathy
Zhiyi Wang, Ningzhi Zhang, Pei Lin, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 20
Gene therapy for inherited retinal diseases: progress and possibilities
Monica L. Hu, Thomas L. Edwards, Fleur O’Hare, et al.
Clinical and Experimental Optometry (2021) Vol. 104, Iss. 4, pp. 444-454
Closed Access | Times Cited: 84
Critical analysis of techniques and materials used in devices, syringes, and needles used for intravitreal injections
Gustavo Barreto Melo, Natasha Ferreira Santos da Cruz, Geoffrey G. Emerson, et al.
Progress in Retinal and Eye Research (2020) Vol. 80, pp. 100862-100862
Closed Access | Times Cited: 81
Optimizing Precision Medicine for Public Health
Gemma A. Bilkey, Belinda L. Burns, Emily P. Coles, et al.
Frontiers in Public Health (2019) Vol. 7
Open Access | Times Cited: 79
Gene therapy strategies for glaucoma from IOP reduction to retinal neuroprotection: Progress towards non-viral systems
Antoine M. Hakim, Benjamin Guido, Lokesh Narsineni, et al.
Advanced Drug Delivery Reviews (2023) Vol. 196, pp. 114781-114781
Closed Access | Times Cited: 33
The Role of Müller Cells in Diabetic Macular Edema
Dongwei Lai, Yang Wu, Chuhan Shao, et al.
Investigative Ophthalmology & Visual Science (2023) Vol. 64, Iss. 10, pp. 8-8
Open Access | Times Cited: 24
Diabetic Retinopathy: New Treatment Approaches Targeting Redox and Immune Mechanisms
Qi Tang, Francesco Buonfiglio, Elsa Wilma Böhm, et al.
Antioxidants (2024) Vol. 13, Iss. 5, pp. 594-594
Open Access | Times Cited: 14
Gene Therapy Intervention in Neovascular Eye Disease: A Recent Update
Fan-Li Lin, Peng‐Yuan Wang, Yu-Fan Chuang, et al.
Molecular Therapy (2020) Vol. 28, Iss. 10, pp. 2120-2138
Open Access | Times Cited: 58
Evolving AAV-delivered therapeutics towards ultimate cures
Xijing He, Brian Anugerah Urip, Zhenjie Zhang, et al.
Journal of Molecular Medicine (2021) Vol. 99, Iss. 5, pp. 593-617
Open Access | Times Cited: 55
RNA Editing as a Therapeutic Approach for Retinal Gene Therapy Requiring Long Coding Sequences
Lewis E. Fry, Caroline F. Peddle, Alun R. Barnard, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 777-777
Open Access | Times Cited: 54
Development of Highly Efficient Dual‐AAV Split Adenosine Base Editor for In Vivo Gene Therapy
Yuxi Chen, Shengyao Zhi, Weiliang Liu, et al.
Small Methods (2020) Vol. 4, Iss. 9
Open Access | Times Cited: 51
Changing trends in the development of AAV-based gene therapies: a meta-analysis of past and present therapies
Tamara Burdett, Samir Nuseibeh
Gene Therapy (2022) Vol. 30, Iss. 3-4, pp. 323-335
Closed Access | Times Cited: 36
New Aspects on the Treatment of Retinopathy of Prematurity: Currently Available Therapies and Emerging Novel Therapeutics
Juhee Ryu
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8529-8529
Open Access | Times Cited: 33
Nanoparticles-mediated CRISPR-Cas9 gene therapy in inherited retinal diseases: applications, challenges, and emerging opportunities
Yueh Chien, Yu‐Jer Hsiao, Shih‐Jie Chou, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 32
Corneal Regeneration Using Gene Therapy Approaches
Subhradeep Sarkar, Priyalakshmi Panikker, Sharon D’Souza, et al.
Cells (2023) Vol. 12, Iss. 9, pp. 1280-1280
Open Access | Times Cited: 19
Gene therapy and the adeno‐associated virus in the treatment of genetic and acquired ophthalmic diseases in humans: Trials, future directions and safety considerations
Charmaine A. Ramlogan‐Steel, Aparna Murali, Sławomir Andrzejewski, et al.
Clinical and Experimental Ophthalmology (2018) Vol. 47, Iss. 4, pp. 521-536
Closed Access | Times Cited: 52
Neuroprotection in Glaucoma: Towards Clinical Trials and Precision Medicine
Tasneem Khatib, Keith R. Martin
Current Eye Research (2019) Vol. 45, Iss. 3, pp. 327-338
Closed Access | Times Cited: 51
Updates on Gene Therapy for Diabetic Retinopathy
Jiang-Hui Wang, Georgina Eloise Roberts, Guei‐Sheung Liu
Current Diabetes Reports (2020) Vol. 20, Iss. 7
Open Access | Times Cited: 46
Biochemical mechanisms of aggregation in TGFBI-linked corneal dystrophies
Nadia Sukusu Nielsen, Ebbe Toftgaard Poulsen, Marie V. Lukassen, et al.
Progress in Retinal and Eye Research (2020) Vol. 77, pp. 100843-100843
Open Access | Times Cited: 44
An Overview of the Genetics of ABCA4 Retinopathies, an Evolving Story
Saoud Al‐Khuzaei, Suzanne Broadgate, Charlotte R. Foster, et al.
Genes (2021) Vol. 12, Iss. 8, pp. 1241-1241
Open Access | Times Cited: 40
Page 1 - Next Page

Scroll to top